Abstract
A range of novel N-terminal lipid-functionalized peptide nucleic acid (PNA) monomers have been prepared and their abilities to inhibit HIV-1 reverse transcriptase and integrase have been examined.
Acknowledgments
This work was supported by the EU FP6 IP grant “Targeting Replication and Integration of HIV” (TRIoH, LSHB-CT-2003-503480).